Glutathione is the master antioxidant that recycles Vitamin C Anth <[email protected]> wrote in message news:[email protected]... > http://www.saveyourheart.com/Nutritional%20Approach%20Ess- > ay.html Anth > > What is Glutathione? It is the body's essential health aid. This small protein comprised of 3 amino acids, produced naturally in the body, maintains the three critical functions of (A)ntioxidation, (I)mmune system booster and (D)etoxification. (A.I.D.) Glutathione precursors in the body make cancer cells more susceptible to chemotherapy and radiation, but make healthy cells more resistant. Every person's life depends on Glutathione. Without it, your cells would disintegrate from unrestrained oxidation, your body would have little resistance to bacteria, viruses and cancer, and your liver would eventually shrivel up from the accumulation of toxins. Your liver has the highest amount of Glutathione in your body. Glutathione is a detoxifier therefore it is only natural that it supports the liver's function. Glutathione is not a common household word. Even Doctors usually only have a vague idea about it. In the last 5 years there have been over 30,000 medical articles about it. This scientific understanding will eventually become common knowledge. When you search the Internet National Library of Medicine, PubMed you will find over 53,000 references to Glutathione. http://www4.ncbi.nlm.nih.gov/entrez/query.fcgi Example: Targeted Search -> Glutathione [ALL] cancer ...find over 7,000 medical journals associating Glutathione and cancer. The Journal of Applied Physiology has about 145 articles featuring Glutathione. A very good booklet about it is available. The booklet is called: Glutathione Its role in cancer & anticancer therapy. Written by Doctor Jimmy Gutman MD, FACEP. Doctor Gutman tours North America lecturing about this topic educating other Doctors and medical communities. His position as Chief Resident at Montreal General Hospital Emergency Department is well documented. Each and every cell in your body is responsible for it's own supply of Glutathione, and must have the necessary raw materials to make it. Glutathione is always in demand and is rapidly consumed when we experience illness, fatigue, and even exercise. Some well know causes of Glutathione depletion are poor diet, caffeine, pollution, drugs, radiation, stress, injury, trauma, burns and infection. Glutathione levels also diminish as we age and many diseases normally associated with aging have been linked to Glutathione deficiency. Researchers know the value of antioxidants in good health, as well as the treatment of diseases involving oxidative attack by free radicals. A new branch of medicine is Free Radical Biology. Because all other antioxidants depend on the presence of Glutathione to function properly, scientists call it "The Master Antioxidant." This master antioxidant is responsible for the normal functional limits of vitamin's C & E, peroxide, and lipoic acid. Elevated Glutathione levels enable the body to produce more white blood cells, the front line defense of your immune system. Glutathione fights off invading disease-causing afflictions. The effects of cancer radiation and chemotherapy treatments are diminished by raising your internal Glutathione levels. Glutathione plays a central role in the functions of these immune cells. The limiting factor in the proper activity of our lymphocytes (white blood cells) is the availability of Glutathione. Glutathione is 'food' for your immune system. Glutathione is also for detoxification. Doctors and toxicologists use Glutathione promoting drugs like NAC (N- acetylcysteine), OTC (ornithine decarboxdecarboxylase procysteine), OTZ (oxothiazolidine carboxylate) and Procysteine to detoxify certain types of drug overdoses including Tylenol. These drugs have serious side effects and often contribute to Glutathione imbalance and depletion. Low Glutathione levels in your liver causes more toxins to circulate through your body resulting in damage to individual cells and organs. Your liver has the highest level of Glutathione in your body, and as we know the liver is the detoxifier. Some Natural ways to raise Glutathione levels have been attempted. Glutathione itself taken orally in pill or powder form is not particularly helpful to the body. A small amount may make it into the bloodstream but most gets lost in the digestive process and cannot raise intracellular Glutathione levels. It may even lead to a possible decrease in blood Glutathione. Oral, Inhaled, Injected Glutathione and Cysteine are both unstable and toxic. Cysteine (L Cysteine) is toxic. Methionine contributes to hardening of the arteries. Melatonin is under investigation as suspicious to good health. Glutamine causes gastrointestinal upset, kidney and liver concerns. Lipoic Acid is still under investigation, Silymarin has liver concerns, gas, cramps, and diarrhea. The Solution. Your body has to produce (synthesize) Glutathione intracellularly.inside your cells. It has been discovered that only one whey protein has the key ingredients for natural Glutathione production. Most whey powders including ones in health food stores and nutritional supply stores vary in protein content. They have protein breakdown, fat content, lactose content, milk from cows subjected to antibiotics and steroids, pasteurization to denature them and loose bioactivity. Common whey powders are not bioactive, and do not act as Glutathione precursors. An Undenatured Bioactive Whey Protein containing high levels of non-denatured protein & Cysteine is the only natural way to boost or increase your body's internal Glutathione level. There is only one company in the world with such a product. Immunotec Research Canada Limited. Product identification: HMS-90 In Canada, Immunocal in the United States. Canada will not allow the US name because it suggests that the product has something to do with 'immune' benefits. The Canadian name (HMS-90) is a contraction of Humanized Milk Serum having 90% protein. The Canadian name might be more interesting because it shows they are actually replicating Mother's milk for anyone. Mother's milk has the same ingredients and it is nature's way to boost the immune system of a newborn. Immunotec's Glutathione precursor is a Bioactive whey based product having 90% protein and is steroid free, antibiotic free, lactose free, fat free. They have invested 22 years of research to complete the discovery of the product. There has been over 10 Million dollars invested in this research. The scientific discoveries were supported by Medical Doctors and Scientists and Grants from the Canadian Government and the Canada Research Council. Product development was done in laboratories at McGill University in conjunction with Montreal Hospital, Montreal Children's Hospital Research Institute, Jewish General Hospital, Institute Pasteur Paris, France, Centre National de la Recherche Scientifique Paris, France. There are 23 Completed Clinical Studies in Humans. Therefore they are beyond the discovery level. Immunotec Research has been granted 10 International "Method-Of- Use" patents including 5 for Cancer (chemotheric therapy) and 2 patents for H.I.V. Two patents for boosting the immune system. These are critical for cancer treatment, cancer prevention and immune system compromised human health concerns. The immune system patents also help H.I.V. and cancer patients with energy loss, hair loss, and immune system breakdown. The transition of H.I.V. to A.I.D.S. is when the body has reached a Glutathione deficiency. Immunocal is listed in the 2002 US Physician's Desk Reference. Immunocal is the only natural product listed in the 2002 US Pharmacy (Red) Book. Immunocal is the only natural product covered by 2 major drug plans (Medicare & Medicaid) There are over 495 Medical Journal Listings about this natural product at the National Library of Medicine "PubMed" Med Line Internet Site. http://www4.ncbi.nlm.nih.gov/entrez/query.fcgi Search -> Immunocal -< A search at www.google.com will find a few of the Doctors involved in the medical science of this natural product. Dr. Gustavo Bounous, Dr. Allen Somersall, Dr. Jimmy Gutman, Dr. Jerome Waters, Dr. Roger Mazlen, Dr. Robert I. Bender. Gustavo Bounous MD, Immunotec's Director of Research and Development, has had a distinguished academic career and has co-authored numerous articles on proteins and the immune system in major professional journals worldwide. After completing his studies at the University of Turin in Italy, he was awarded the 1965 medal of the Royal College of Physicians and Surgeons. In 1968, he was named Career Investigator of the Medical Research Council of Canada; a post that he held for a period of 25 years. It was in 1978 that he initiated his studies on the discovery and development of a dietary protein source from whey concentrate; work that eventually led to the creation of HMS 90, Immunocal. In April, 1998 Mr. Chuck Roberts, President of Immunotec Research, testified before a select committee of Canadian Parliament about Government regulations concerning the marketing of natural food products, with perceived health benefits, like HMS-90. It is an example of the new category of nutriceuticals, as some in the industry call them. In Canada there are only 2 recognized broad categories for products normally ingested by mouth: foods and drugs. The law is very prohibitive regarding any claims for 'food' products and naturally demands much more justification, specification, and regulation in the distribution and use of 'drugs.' The United States now recognizes the 'Nutriceutical' category. Immunotec made their presentation with published data, scientific studies and with method of use patents in hand. Only the future will determine when the Canadian Government will allow the third category in Canada. The encouraging part is when the press arrive at the companies headquarters in Quebec seeking to expose unconfirmed medical claims. Once the diligent journalists see the published research reports from reputable medical journals, see the credentials of the investigators, see results of clinical trials and talk with Doctor Bounous and Mr. Roberts, they leave with a new appreciation for a serious company which understands that until the laws and regulations are changed in Canada, it cannot legally make medical claims about their natural 'food' product. Immunotec Research had a marketing decision to make. There were international drug companies negotiating for the distribution rights to a product that qualified for cancer and H.I.V. therapeutic treatment patents. During negotiations senior drug company executives advised Immunotec to find alternative methods of distribution. The marketing and consumer costs of a 'drug' category would have meant that the product cost for the average person would have been too high. Dieter Beer who is an Immunotec Research partner and marketing business expert was advised that direct distribution would be a much better avenue. This method of distribution has allowed the launch of HMS-90 4 years ago through a system of individuals and small businesses who represent the companies best interests and the distribution of information about the company and it's products. This has proven to be a perfect solution to the 'drug', 'food' dilemma as it now exists. The result is availability of a world class health maintenance product at a very low cost. The ethical side of the Immunotec decision is that the average person has access to a scientifically, medically proven, health maintenance product at an affordable cost. This is a saving to the existing Health Care system because of a few factors. There is no Doctor cost to prescribe the product. There is no cost to the O.H.I.P. healthcare resources and funds. And the fact that if people's Glutathione levels are elevated there will be less sickness, diseases and health care costs. This would also cost employers less sick day payouts. If people are healthier, with less disease they will enjoy a higher quality of life. Traditional drugs have harmful side effects that a person's body has to deal with. To utilize something that has no side effects and is completely complimentary to conventional treatments from medical Doctors is an intelligent choice for a Naturopathic Doctor to administer and prescribe to their patients. Historically hospitals were Naturopathic in the way they treated patients. In the past 200 years a change has happened. Drug companies have had a major influence in the training of Doctors and the operations of Hospitals. This has been a financial boom to the drug company industries. History now shows us that antibiotics are not working as well any more. 'Super' bugs are now created due to immunity to antibiotics. Traditional drugs are taxing to a person's immune system. People are looking back to see if the 'old' days had any health maintenance aspects being ignored today. Health food stores are flourishing, alternative health solutions are being published daily in newspapers. People are more informed by what has happened in the past. They can learn what things have caused health distress, sickness, etc. in the past. We can discover information now on the Internet. Currently HMS- 90 is available in 10 gram packages and production can keep up with the current sale demands. There are about 160,000 people per month using this product. This represents a large group of people who are raising their Glutathione levels in the quest for good health. There are no opposing perspectives of the key stakeholders. Four out of the five company executives came out of retirement to launch Immunotec Research Limited. These stakeholders learned what this product will do for people's health in a natural way and they support it 100%. Skeptics will have to do their own research about Glutathione. Many medical and scientific discoveries in the past were not accepted until people were given the tools and proofs needed to be educated. Traditional Canadian hospitals and medical Doctors are closely associated with Pharmaceutical drug companies. I think that it would be very difficult for a natural product to be endorsed and prescribed in Canadian hospitals. This may change in the future. In the United States Medicare and Medicaid drug plans reimburse the product and there are many medical Doctors that prescribe it and many hospitals encourage the use of it. The 'Nutriceutical' category in the United States is the reason for this. One action option is to have HMS-90 prescribed in hospitals by Doctors. This will increase patient's chances of regaining health and experiencing less adverse effects of traditional drugs. HMS- 90 is complimentary to current drug therapies. HMS-90 will change how medicine is practiced today. Using this product will decrease spending of hospital funds, Doctor resources and medication costs. Alternative and medical doctors can prescribe this product for their patients. It is just the education process they must go through before realizing the health potential and disease fighting process that happens with elevated levels of Glutathione. If HMS-90 is endorsed by the conventional medical fields patients may be confused by the simplicity of the product. Patients will need education and information about the product. People will have to start thinking about prevention and be proactive about their health instead of reacting to ongoing health and sickness concerns. Some restrictions are given for prescribing HMS-90. People who have a specific milk protein allergies, those who are in kidney failure, and anyone on immunosuppressive drugs or medications should not take this product without medical supervision. This product is available from a private Canadian company based in Quebec. The distribution system they have chosen means there will be no inflated product costs because of advertising, warehousing, retail store costs and related traditional marketing methods. The negative side of this is that hospital patients and the general public will not be exposed to it in traditional ways. Glutathione has an important role to play in the treatment and prevention of hundreds of diseases. Clinical tests show that raised Glutathione levels may address some of the major health issues of our time. Possible clinical applications of high body levels of Glutathione include: Aging, Cardiovascular, Digestive, Toxicology, Infectious disease & Immunology, Cancer, Pulmonary and Metabolic health concerns, burns and many injuries. Glutathione supplies the tools for the body to fight off these threats naturally. An interesting fact is that Alzheimer's & Parkinson's patients have very low Glutathione levels in their bodies. At autopsy they are found to be about 40% deficient in Glutathione according to information from Doctor Jimmy Gutman. PubMed has about 95,000 completed studies published about Glutathione and Alzheimer's & Parkinson's. Naturopathic Doctors act to identify and remove obstacles to healing and recovery, and to facilitate and increase this inherent self-healing process. Naturopathic Doctors share information and knowledge with their patients and encourage self- responsibility for health. And to use methods and medicines which minimize the risk of harmful side effects, using the least force necessary to diagnose and treat. HMS-90 matches the principals of the Naturopathic College and its mandate to help people heal themselves naturally. Listen to a video presented by Doctor Gutman about Glutathione http://www.immunotec.com/page.asp?intNodeID=10682 Please feel free to review these notable Internet sites about Glutathione. http://www.thorne.com/altmedrev/fulltext/glut.html http://www.immunesystemsupport.com/wpcagmct/gmct.html http:- //www.fda.gov/ohrms/dockets/ac/00/slides/3652s1_05/sld001.h- tm http://www.carb.nist.gov/gilliland_group/molecules/gst.html http://micro.magnet.fsu.edu/aminoacids/pages/glutathione.ht- ml http://www.aids.org/immunet/atn.nsf/page/ZQX26601.html REFERENCES 1. Meister A. The antioxidant effects of Glutathione and ascorbic acid. In: Oxidative Stress, Cell Activation and Viral Infection. C. Pasquier et al (Eds.). Birkauser Verlag, Basel, Switzerland, 101-11, 1994. 2. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 52: 711-60, 1983. 3. Kaplowitz N, Aw TY, Ookhtens M. The regulation of hepatic glutathione. Ann Rev Pharmacol Toxicol 25: 715-44, 1985. 4. Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol 43: 667-9, 1992. 5. Meister A. New aspects of glutathione biochemistry and transport selective alteration of glutathione metabolism. Nutr Rev 42: 397-410, 1984. 6. Bounous G, Gold P. The biological activity of undenatured dietary whey proteins: role of glutathione. Clin Invest Med 14: 296-309, 1991. 7. Droege W, Eck HP, Mihm S, Galter D. Abnormal redox regulation in HIV infection and other immunodeficiency diseases. In: Oxidative Stress, Cell Activation and Viral Infection. C. Pasquier et al (Eds). Birkauser Verlag, Basel, Switzerland, 285-99, 1994. 8. Noelle RJ, Lawrence DA. Determination of glutathione in lymphocytes and possible association of redox state and proliferative capacity of lymphocytes. Biochem J 198: 571-9, 1981. 9. Fidelus RK, Tsan MF. Glutathione and lymphocyte activation: A function of aging and auto-immune disease. Immunology 61: 503-8, 1987. 10. Staal FJT, Roederer M, Israelski DM, Bubp J et al. Intracellular glutathione levels in T cell subsets decreases in HIV-infected individuals. AIDS Res and Hum Retro- viruses 8: 305-11, 1992. 11. Herzenberg L, De Rosa S, Dubs G, Roederer M et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 94: 1967-72, 1997. 12. Bounous G, Stevenson MM, Kongshavn PAL. Influence of dietary lactalbumin hydrolysate on the immune system of mice and resistance to Salmonellosis. J Infect Dis 144: 281, 1981. 13. Bounous G, Kongshavn PAL. Influence of dietary proteins on the immune system of mice. J Nutr 112: 1747-55, 1982. 14. Bounous G, Letourneau L, Kongshavn PAL. Influence of dietary protein type on the immune system of mice. J Nutr 113: 1415-21, 1983. 15. Bounous G, Kongshavn PAL. Influence of protein type in nutritionally adequate diets on the development of immunity. In: Absorption and Utilization of Amino Acids. M. Friedman (Ed.). Boca Raton, Florida: CRC Press, vol. 2, 219-32, 1989. 16. Bounous G, Batist G, Gold P. Immunoenhancing property of dietary whey protein in mice: role of glutathione. Clin Invest Med 12: 154-61,1989. 17. Bounous G, Shenouda N, Kongshavn PAL, Osmond DG. Mechanism of altered B-cell response induced by changes in dietary protein type in mice. J Nutr 18: 1409-17, 1985. 19. Hirai R, Nakai S, Kikuishi H, Kawai K. Evaluation of the Immunological Enhancement Activities of Immunocal. Otsuka Pharmaceutical Co. Cellular Technology Institute, Dec. 13, 1990. 20. Eigel WN, Butler JE, Ernstrom CA, Farrell HM et al. Nomenclature of proteins of cow's milk. Fifth revision. J Dairy Sci 67: 1599-631, 1984. 21. Goodman RE, Schanbacher FL. Bovine lactoferrin in RNA: Sequence, analysis, and expression in the mammary gland. Biochem Biophys Res Commun 22: 75-84, 1991. 23. Duncan B, Ey J, Holberg CJ, Wright AL et al. Exclusive breast-feeding for at least 4 months protects against otitis media. Paediatrics 91: 867-72, 1993. 24. Frank AL, Taber LN, Glezen WP, Kasel GL et al. Breast- feeding and respiratory virus infection. Paediatrics 70: 239-45, 1982. 25. Mather G, Gupta N, Mathur S, Gupta U. et al. Breast- feeding and childhood cancer. Indian Paediatrics 30: 652-7, 1993. 26. Davis MK, Savitz DA, Graubard BI. Infant feeding and childhood cancer. Lancet 1: 365-8, 1988. 27. Richie JP. The role of glutathione in aging and cancer. Exp Gerontol 27: 615-26, 1992. 28. Newberne PM, Butler WH. Acute and chronic effects of aflatoxins B1 on the liver of domestic and laboratory animals: A review. Cancer Res 29: 236-50, 1969. 29. Meerman JHN, Beland FA, Ketterer B, Srai SKF et al. Identification of glutathione conjugates formed from N-hydroxy-2- acetylaminofluorene in the rat. Chem Biol Interact 39: 149-68, 1982. 30. Boyland E, Sims P. The metabolism of benz(a)anthracene and dibenz(a,h)anthracene and their 5,6-dihydro derivatives by rat liver homogenates. Biochem J 97: 7-16, 1965. 31. Waterfall JF, Sims P. Epoxy derivatives of aromatic polycyclic hydrocarbons. The properties and metabolism of epoxides related to benzo(a)pyrene and to 7-8 and 9- dihydrobenzo(a)pyrene. Biochem J 128: 265-77, 1972. 32. Yamazoe Y, Roth RW, Kadlubar FF. Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-9-yl)- benzidine. Carcinogenesis 7: 179-82, 1986. 33. Bounous G, Papenburg R, Kongshavn PAL, Gold P et al. Dietary whey protein inhibits the development of dimethylhydrazine- induced malignancy. Clin Invest Med 11: 213-7, 1988. 34. McIntosh GH, Regester GQ, Le Leu RK, Royle PJ. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 125: 809-16, 1995. 35. Frei E, Bertram B, Wiessler M. Reduced glutathione inhibits the alkylation by N-nitrosodimethylamine of liver DNA in vivo and microsomal fraction in vitro. Chem Biol Interact 55: 123-37, 1985. 36. Roberts JJ, Warwick GP. Mode of action of alkylating agents in formation of S-ethyl cysteine from ethyl methanesulphonate. Nature 179: 1181, 1958. 37. Coles B, Srai SKS, Waynforth B, Ketterer B. The major role of glutathione in the excretion of N, N-dimethyl-4- aminoazobenzene in the rat. Chem Biol Interact 47: 307-23, 1983. 38. Sims P. The metabolism of 3-methylcholanthrene and some related compounds by rat liver homogenates. Biochem J 98: 215-28, 1966. 39. Sims P. The metabolism of 7- and 12-methylbenz(a)anthra- cenes and their derivatives. Biochem J 105: 591-8, 1967. 40. Djuric Z, Coles B, Fifer EK, Ketterer B et al. In vivo and in vitro formation of glutathione conjugates from the K-region epoxides of 1-nitropyrene. Carcinogenesis 8: 1781-6, 1987. 41. Ripple MO, Henry W, Rago R, Wilding G. Prooxidant- antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Nat Cancer Inst 89: 40-8, 1997. 42. Hazelton GA, Lang CA. Glutathione contents of tissues in the aging mouse. Biochem J 188: 25-30, 1980. 43. Lang CA, Richie JP, Chen TS. Differential glutathione and cysteine levels in the brain of the aging mouse. Fed Am Soc Exp Biol, 1988. [Abstract 8327] 44. Lang CA, Naryshkin S, Schneider DL, Mills BJ et al. Low blood glutathione levels in healthy aging adults. J Lab Clin Med 120: 720-5, 1992. 45. Jeandel C, Nicolas MB, Dubois F, Nabey-Belleville F et al. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 46: 275-82, 1989. 47. Calvin HI, Medvedovsky C, Worgul BV. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice. Science 28: 553-5, 1986. 48. Riederer P, Sofic E, Rausch WD, Schmidt B. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J Neurochem 52: 515- 20, 1989. 49. Ebadi M, Srinivasan SK, Baxi MD. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol 48: 1-19, 1996. 50. Kuzuya M, Naito M, Funaki C, Hayahi T et al. Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells. Biochem Biophys Res Commun 163: 1466-72, 1989. 51. Bounous G, Gervais F, Amer V, Batist G et al. The influence of dietary whey protein on tissue glutathione and the diseases of aging. Clin Invest Med 12: 343-9, 1989. 52. Blumberg JB, Meydani SN. Role of dietary antioxidants in aging. In: Nutrition and Aging. Hutchinson MG, Munro HN (Eds.). New York: Academic Press, 85-97, 1986. 53. Birt DF, Baker PY, Hruza DS. Nutritional evaluations of three dietary levels of lactalbumin throughout the lifespan of two generations of Syrian hamsters. J Nutr 112: 2151-60, 1982. 54. Birt DF, Schuldt GH, Salmasi S. Survival of hamsters fed graded levels of two protein sources. Lab Anim Sci 32: 363-6, 1982. 55. Bray TM, Taylor CO. Enhancement of tissue glutathione for antioxidant and immune functions in malnutrition. Biochem Pharmacol 2113-23, 1994. 56. Puri RN, Meister A. Transport of glutathione, as g- glutamylcylsteinylglycyl ester, into liver and kidney. Proc Natl Acad Sci USA 80: 5258-60, 1983. 57. Anderson ME, Powric F, Puri RN, Meister A. Glutathione monoethyl ester: Preparation, uptake by tissues, and conversion to glutathione. Arch Biochem Biophys 239: 538-48, 1985. 58. Birnbaum SM, Winitz M, Greenstein JP. Quantitative nutritional studies with water-soluble, chemically defined diets. III. Individual amino acids as sources of "non-essential" nitrogen. Arch Biochem Biophys 72: 428-36, 1957. 59. Bridgeman MME, Marsden M, MacNee W, Flenley DC et al. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N- acetylcysteine. Thorax 46: 39-42, 1991. 60. Williamson JM, Boettcher B, Meister A. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc Natl Acad Sci USA 79: 6246-9, 1982. 61. Mant TGK, Tempowski JH, Volans GN, Talbot JCC. Adverse reactions to acetylcysteine and effects of overdose. Br Med J 289: 217-19, 1984. 62. Koch SM, Leis AA, Stokic DS, Khawli FA et al. Side effects of intravenous N-acetylcysteine. Am J Respir Crit Care Med 149: A321, 1994. 63. Williamson JM, Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4- carboxylate, a 5-oxo-L, prolinase substrate. Proc Natl Acad Sci USA 78: 936-9, 1981. 64. Baruchel S, Viau G, Olivier R, Bounous G. Nutriceutical modulation of glutathione with a humanized native milk serum protein isolate: Immunocal applications in AIDS and cancer. In: Oxidative Stress and Redox Regulation: Cellular Signaling, AIDS, Cancer and Other Diseases. Symposium May 21- 24, 1996, Institut Pasteur. [In press] 65. Watanabe A, Higuchi K, Yasumura S, Shimizu Y et al. Nutritional modulation of glutathione level and cellular immunity in chronic hepatitis B and C. Hepatology 24: 1883, 1996.
Boy, after reading this,I can only wonder how anybody lives long enough to blow out the 100 candles on their birthday cake without this product. BTW, is there any particular reason one would consult with the Chief Resident of a hospital emergency room on nutritional issues? Last time I did it, it was only about a fractured wrist.
